Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Silybin-phosphatidylcholine complex. Monograph.

[No authors listed]

Altern Med Rev. 2009 Dec;14(4):385-90. Review. No abstract available.

2.

The use of silymarin in the treatment of liver diseases.

Saller R, Meier R, Brignoli R.

Drugs. 2001;61(14):2035-63. Review.

PMID:
11735632
3.

Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats.

Di Sario A, Bendia E, Taffetani S, Omenetti A, Candelaresi C, Marzioni M, De Minicis S, Benedetti A.

Dig Liver Dis. 2005 Nov;37(11):869-76. Epub 2005 Oct 5.

PMID:
16169303
4.
5.
6.

Milk thistle and the treatment of hepatitis.

Giese LA.

Gastroenterol Nurs. 2001 Mar-Apr;24(2):95-7. Review.

PMID:
11847735
7.

Influence of silymarin and its flavonolignans on H(2)O(2)-induced oxidative stress in human keratinocytes and mouse fibroblasts.

Svobodová A, Walterová D, Psotová J.

Burns. 2006 Dec;32(8):973-9. Epub 2006 Sep 29.

PMID:
17011711
8.

Bioavailability of a silybin-phosphatidylcholine complex in dogs.

Filburn CR, Kettenacker R, Griffin DW.

J Vet Pharmacol Ther. 2007 Apr;30(2):132-8.

PMID:
17348898
9.

A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis.

Buzzelli G, Moscarella S, Giusti A, Duchini A, Marena C, Lampertico M.

Int J Clin Pharmacol Ther Toxicol. 1993 Sep;31(9):456-60.

PMID:
8225695
10.

Antioxidant properties of silybin glycosides.

Kosina P, Kren V, Gebhardt R, Grambal F, Ulrichová J, Walterová D.

Phytother Res. 2002 Mar;16 Suppl 1:S33-9.

PMID:
11933137
11.

TNF-alpha as therapeutic target in NASH: tried, but not yet proven.

Chitturi S, Farrell GC.

J Gastroenterol Hepatol. 2007 May;22(5):613-4. No abstract available.

PMID:
17444846
12.

Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats.

Pradeep K, Mohan CV, Gobianand K, Karthikeyan S.

Eur J Pharmacol. 2007 Apr 10;560(2-3):110-6. Epub 2007 Jan 19.

PMID:
17300777
13.

Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature.

Dashti-Khavidaki S, Shahbazi F, Khalili H, Lessan-Pezeshki M.

J Pharm Pharm Sci. 2012;15(1):112-23. Review.

15.

[Effect of silymarin on the anti-fibrosis of liver and its mechanism].

Wang Y, Jia JD.

Zhonghua Yi Xue Za Zhi. 2005 May 11;85(17):1219-21. Review. Chinese. No abstract available.

PMID:
16029603
16.

The protective effects of Hibiscus sabdariffa extract on CCl4-induced liver fibrosis in rats.

Liu JY, Chen CC, Wang WH, Hsu JD, Yang MY, Wang CJ.

Food Chem Toxicol. 2006 Mar;44(3):336-43. Epub 2005 Sep 19.

PMID:
16176854
17.
18.

Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells.

Gharagozloo M, Amirghofran Z.

J Cancer Res Clin Oncol. 2007 Aug;133(8):525-32. Epub 2007 Apr 14.

PMID:
17436018
19.

Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas.

Soto C, Recoba R, Barrón H, Alvarez C, Favari L.

Comp Biochem Physiol C Toxicol Pharmacol. 2003 Nov;136(3):205-12.

PMID:
14659454
20.

Resveratrol. Monograph.

[No authors listed]

Altern Med Rev. 2010 Jul;15(2):152-8. Review. No abstract available.

Supplemental Content

Support Center